Monday, May 06, 2019 8:53:46 AM
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, announced today that David Domzalski, Chief Executive Officer, will present a corporate overview and business update at the Bank of America Merrill Lynch Health Care Conference 2019 on Tuesday, May 14 at the Encore Hotel in Las Vegas, Nevada.
Bank of America Merrill Lynch Health Care Conference
Date: Tuesday, May 14 Time: 5:20pm Eastern Time/2:20pm Pacific Time Loca tion: Encore Hotel, Las Vegas, Nevada Webcast: http://www.veracast.com/webcasts/baml/healthcare2019/id21112470851.cfm About Foamix
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM